{'output': [['Akebia Therapeutics', 'ORG', 'Has', 'vadadustat', 'PRODUCT'], ['Akebia Therapeutics', 'ORG', 'Operate_In', 'Chronic Kidney Disease', 'SECTOR'], ['Akebia Therapeutics', 'ORG', 'Participates_In', 'Phase 2 Study', 'EVENT'], ['Vadadustat', 'PRODUCT', 'Impact', 'Anemia', 'CONCEPT'], ['Vadadustat', 'PRODUCT', 'Operate_In', 'Dialysis-dependent chronic kidney disease', 'SECTOR'], ['Vadadustat', 'PRODUCT', 'Operate_In', 'Non-dialysis dependent chronic kidney disease', 'SECTOR'], ['Mitsubishi Tanabe Pharma Corporation', 'ORG', 'Has', 'Phase 3 Study', 'EVENT'], ['Mitsubishi Tanabe Pharma Corporation', 'ORG', 'Operate_In', 'Japan', 'GPE'], ['Mitsubishi Tanabe Pharma Corporation', 'ORG', 'Participates_In', 'Phase 3 Studies', 'EVENT'], ['Collaboration Agreement', 'EVENT', 'Relate_To', 'Akebia Therapeutics', 'ORG'], ['Collaboration Agreement', 'EVENT', 'Relate_To', 'Mitsubishi Tanabe Pharma Corporation', 'ORG'], ['Phase 3 Studies', 'EVENT', 'Impact', 'Akebia Therapeutics', 'ORG'], ['Phase 3 Studies', 'EVENT', 'Impact', 'Mitsubishi Tanabe Pharma Corporation', 'ORG'], ['Milestone Payments', 'EVENT', 'Relate_To', 'Akebia Therapeutics', 'ORG'], ['Milestone Payments', 'EVENT', 'Relate_To', 'Mitsubishi Tanabe Pharma Corporation', 'ORG']]}